Clinical efficacy of agonist toll-like receptor 9 on the process of reparations after loop conization (LEEP) of the cervix

Abstract

The aim of this study to explore the use of the agonist Toll-like receptors 9 (TLR 9) in the postoperative period after the LEEP, performed for cervical intraepithelial neoplasia, influences the process tissue repair cervix.Materials and methods. In a randomized, longitudinal, prospective, comparative study included 70 patients with squamous intraepithelial lesions (HSIL и LSIL). Patients first test group (n = 36) was obtained postoperatively as a TLR agonist Derinat 9 immunomodulator. Two patients, the control group (n = 34), postoperative not administered any medication drugs. In the process of diagnosis all patients were performed conventional cytology and colposcopy, PCR-test for human papillomavirus (HPV). These parameters were examined postoperatively at 1 month and 6 months.Results. Systemic administration agonist TLR 9, drug Derinat in clean postoperative wound of the cervix pathogenetically justified because it, together with the alteration leads to a synergistic effect to the reparative function of the macrophages through activation of Toll-like receptors 9 and the subsequent synthesis of cytokines directly accelerates the process of repair and immune supervision of malignant transformation cervical intraepithelial neoplasia tissues.Conclusion. Patients after LEEP is recommended the appointment of the drug Derinat, agonist of toll-like receptor 9, immunomodulator with the reparative effect, intramuscular injection of 15 mg/mL, 75 mg after 24 hours number 10.